Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 15/03/20001 min de lecture
Ophthalmic and Topical Dosage Form New Animal Drugs; Milbemycin Oxime Solution
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Novartis Animal Health US, Inc. The NADA provides for veterinary prescription use of milbemycin oxime solution to treat ear mite infestations in cats and kittens 8 weeks of age and older.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →